Adenosine for SVT: Dosing, Technique, and Pitfalls

Supraventricular tachycardia (SVT) is one of the most common arrhythmias you'll encounter in clinical practice – whether in the emergency department, prehospital setting, or intensive care unit. Hemodynamically stable patients with regular narrow-complex tachycardia represent the classic indication for adenosine: a drug that works within seconds when administered correctly, but can completely fail with improper technique. This is precisely where the challenge lies. The extremely short half-life of less than ten seconds makes adenosine a remarkably safe pharmacological agent on one hand, but on the other, a drug that must be administered with flawless technique. This article covers the pharmacological fundamentals, the correct procedure using the rapid-flush technique, the relevant contraindications – particularly in preexcitation – as well as utilizing the diagnostic window.

Pharmacology: Why Adenosine Is So Unique

Adenosine is an endogenous purine nucleoside that causes transient blockade of conduction at the AV node via A1 receptors. This effect is based on activation of potassium channels (IKAdo) and inhibition of calcium influx, leading to hyperpolarization of AV nodal cells.

Pharmacokinetic Characteristics

• Half-life: Less than ten seconds – adenosine is broken down extremely rapidly by adenosine deaminase and cellular uptake in erythrocytes and endothelial cells.
• Onset of action: 10–20 seconds after reaching the heart.
• Duration of action: Maximum 30–60 seconds – after which the effect is completely reversible.
• Metabolism: No hepatic or renal elimination – breakdown occurs directly in the blood and tissues.

This kinetic profile has two key consequences for clinical practice: First, the drug must reach the heart as quickly as possible before it is degraded in the venous system. Second, side effects are common but virtually always self-limiting.

Typical Side Effects

Patients should be informed about transient symptoms before administration:

• Chest tightness or pressure sensation (very common)
• Flushing and sensation of warmth
• Shortness of breath, dyspnea
• Nausea
• Brief asystole pauses (desired and therapeutic)
• Transient bradycardia

These symptoms typically last less than 30 seconds. Prior counseling significantly reduces patient anxiety – the brief asystole in particular can be perceived as dramatic without warning.

Indication: When Is Adenosine the Drug of Choice?

The AHA guidelines clearly position adenosine in the algorithm for stable narrow-complex tachycardia:

1. Hemodynamically stable, regular narrow-complex tachycardia after unsuccessful vagal maneuvers → adenosine is first-line therapy.
2. Regular wide-complex tachycardia, when SVT with aberrant conduction is suspected → adenosine can be used diagnostically and therapeutically (caveat: only with a regular rhythm).
3. Diagnostic tool to unmask the underlying rhythm disturbance (e.g., atrial flutter, atrial tachycardia).

Typical SVT Mechanisms That Respond to Adenosine

• AV nodal reentrant tachycardia (AVNRT): The most common SVT mechanism (~60%). The AV node is an integral part of the reentry circuit – adenosine reliably terminates the tachycardia.
• AV reentrant tachycardia (AVRT): With an accessory pathway (e.g., WPW syndrome). Orthodromic AVRT uses the AV node in the antegrade direction – adenosine is effective here. Special precautions apply to the antidromic form (see below).
• Focal atrial tachycardia: Adenosine terminates this less frequently but can unmask P-wave morphology through transient AV block.

Dosing According to AHA Guidelines

Dosing follows an escalating regimen:

Dose	Adults	Pediatric
1st dose	6 mg rapid IV	0.1 mg/kg (max. 6 mg)
2nd dose	12 mg rapid IV	0.2 mg/kg (max. 12 mg)
3rd dose	12 mg rapid IV (repeat possible)	0.2 mg/kg (max. 12 mg)

Dose Adjustments

Several clinical situations require modification:

• Central venous catheter (CVC): Reduce starting dose to 3 mg – the shorter distance to the heart significantly reduces degradation.
• Heart transplant patients: Reduce starting dose to 3 mg – the denervated heart shows markedly increased sensitivity.
• Dipyridamole/carbamazepine use: Dose reduction, as both substances inhibit adenosine breakdown and potentiate the effect.
• Theophylline/caffeine: Competitive antagonism at the adenosine receptor – higher doses may be required. At high theophylline levels, adenosine may be ineffective.

The Rapid-Flush Technique: The Critical Factor

The most common cause of apparent adenosine failure is not an incorrect indication, but faulty administration technique. The extremely short half-life requires the drug to be administered as a rapid bolus with immediate flushing.

Step-by-Step Instructions

1. Check access: Large-bore peripheral IV access, ideally in the antecubital fossa or proximal to it. Dorsal hand IVs are significantly less effective due to the longer distance to the heart.

2. Stopcock setup: Place a three-way stopcock as close to the IV cannula as possible. Connect the adenosine syringe to one port and a 20 mL normal saline syringe to the other.

3. Start monitoring: Activate a 12-lead ECG (preferred) or at minimum continuous rhythm monitoring with recording function – ideally with rhythm strip printout.

4. Inject adenosine: As quickly as possible as a bolus (within 1–2 seconds).

5. Immediate flush: Immediately afterward – without any delay – push the 20 mL normal saline also as a rapid bolus. The stopcock is turned without interrupting the connection.

6. Elevate the arm: Raise the patient's arm after injection to accelerate venous return.

Common Errors in Administration

• Too slow injection: Adenosine must not be "pushed slowly" – it must be a true bolus.
• Delay between bolus and flush: Every second of delay significantly reduces effectiveness.
• Distal access: An IV on the dorsum of the hand or forearm prolongs transit time to the heart. If only a distal access is available, a particularly aggressive flush should be performed.
• No stopcock: Switching syringes costs critical seconds. The two-syringe stopcock technique is the gold standard.
• No recording: Without ECG documentation, the diagnostic window is lost.

Alternative: Two-Person Technique

If no stopcock is available, a two-person technique can be employed: Person 1 injects adenosine, Person 2 immediately injects the flush through the same access. Coordination must be clearly agreed upon beforehand – a "Ready – Go!" command has proven effective.

The Diagnostic Window: More Than Just Therapy

One of the most valuable aspects of adenosine administration is frequently underestimated: the diagnostic window. During transient AV blockade, atrial signals are unmasked that would otherwise be buried in the rapid ventricular rate.

What You Can See in the Diagnostic Window

• Atrial flutter: Sawtooth pattern (typically in leads II, III, aVF) becomes visible when AV conduction is briefly blocked. The tachycardia recurs after the adenosine effect wears off.
• Atrial tachycardia: P-wave morphology and axis become visible. The tachycardia may not terminate, but the diagnosis becomes clear.
• Sinus tachycardia: Gradual slowing and re-acceleration of heart rate – no abrupt termination.
• AVNRT/AVRT: Abrupt termination with sinus rhythm – the AV node is part of the reentry circuit.

Documentation

The ECG recording during adenosine administration should be understood and documented as a diagnostic tool:

• Before administration: Secure a 12-lead ECG of the tachycardia
• During administration: Continuous rhythm strip recording
• After administration: 12-lead ECG in sinus rhythm (if converted)

Particularly important: A 12-lead ECG in sinus rhythm after successful cardioversion can reveal preexcitation (delta wave) that was not visible during the tachycardia.

Contraindications and Precautions

Absolute Contraindications

• Known bronchial asthma: Adenosine can trigger severe bronchospasm. COPD without an asthmatic component is considered a relative contraindication – caution is warranted, but adenosine is not absolutely contraindicated.
• Second-degree or third-degree AV block (without pacemaker): The additional AV blockade can lead to prolonged asystole.
• Sick sinus syndrome (without pacemaker)

The WPW Problem: Antidromic Tachycardia and Atrial Fibrillation

This is one of the most critical pitfalls:

Orthodromic AVRT in WPW: The impulse travels antegrade through the AV node and retrograde through the accessory pathway. Adenosine blocks the AV node and interrupts the reentry circuit → effective and safe.

Antidromic AVRT in WPW: The impulse travels antegrade through the accessory pathway and retrograde through the AV node. This produces a wide-complex tachycardia. Adenosine can theoretically be used here since the AV node is still part of the circuit – however, distinguishing this from VT is difficult.

Atrial fibrillation in WPW – the dangerous combination: In atrial fibrillation with antegrade conduction over the accessory pathway, an irregular wide-complex tachycardia is seen. Adenosine (and other AV nodal blocking agents such as verapamil or digoxin) are strictly contraindicated here. The reason: AV nodal blockade removes the "brake" on conduction through the accessory pathway and can lead to ventricular fibrillation.

Practical rule: No adenosine for irregular wide-complex tachycardia. For regular wide-complex tachycardia, adenosine may be considered under continuous monitoring with defibrillator backup.

Additional Precautions

• Defibrillator at the bedside: Although rare, malignant arrhythmias can occur after adenosine administration – particularly with unrecognized preexcitation.
• Recurrence of SVT: In up to 15% of cases, the SVT recurs after initial termination. Repeat dosing or maintenance therapy (e.g., verapamil, diltiazem, beta-blockers) may be required.
• Pregnancy: Adenosine is considered relatively safe in pregnancy and can be used for hemodynamically significant SVT.

When Adenosine Doesn't Work: Differential Diagnostic Approach

A lack of response to adenosine (assuming correct technique) should prompt the following considerations:

1. Verify technique: Was it truly a rapid bolus with immediate flush via a proximal access?

2. Drug interactions: Is the patient taking theophylline or has she/he recently consumed large amounts of caffeine?

3. Reconsider the diagnosis:

   • Atrial flutter with 2:1 conduction mimics a regular narrow-complex tachycardia – adenosine does not terminate the flutter but unmasks flutter waves.
   • Atrial tachycardia responds inconsistently to adenosine.
   • Ventricular tachycardia (in wide-complex tachycardia): Adenosine has no effect on most VTs (exception: fascicular VT, which responds to verapamil, and right ventricular outflow tract tachycardia, which may actually respond to adenosine).

4. Next step in the algorithm: Calcium channel blockers (verapamil 2.5–5 mg IV over 2 minutes, repeatable) or beta-blockers (esmolol, metoprolol) – provided there are no contraindications.

Special Clinical Scenarios

Adenosine in Pediatric Patients

SVT is the most common symptomatic arrhythmia in children. Management follows the PALS algorithm:

• Vagal maneuvers (ice water bag to the face in infants, Valsalva in older children)
• Adenosine 0.1 mg/kg rapid IV (max. 6 mg)
• If ineffective: 0.2 mg/kg (max. 12 mg)
• The rapid-flush technique is identical – with small children and small IV access, pay particular attention to flush speed.

Adenosine in Wide-Complex Tachycardia

Differentiating between SVT with aberrancy and VT remains one of the greatest challenges in acute care medicine. Adenosine can be used as a diagnostic tool in regular wide-complex tachycardia – but only under the following conditions:

• Continuous monitoring
• Defibrillator armed and ready
• The tachycardia is regular (irregular wide-complex tachycardia → no adenosine)
• No suspicion of atrial fibrillation with preexcitation

Summary: Checklist for Adenosine Administration

• Indication confirmed: stable, regular narrow-complex tachycardia after unsuccessful vagal maneuvers
• Contraindications excluded (asthma, high-degree AV block, irregular wide-complex tachycardia)
• Proximal large-bore IV access in place
• Three-way stopcock with adenosine syringe and 20 mL normal saline syringe prepared
• ECG recording started
• Defibrillator at the bedside
• Patient informed about brief side effects
• Adenosine 6 mg as rapid bolus → immediate 20 mL normal saline flush → elevate arm
• ECG strip documented and interpreted
• If ineffective: 12 mg with identical technique, repeat if necessary

Practical Training

Adenosine administration for SVT sounds simple in theory – but the rapid-flush technique, handling the three-way stopcock, interpreting the diagnostic window, and decision-making in wide-complex tachycardias all require hands-on practice. In the ACLS courses and ACLS refresher courses from Simulation Tirol, you train these scenarios under realistic conditions on a simulator, including real-time ECG interpretation and the structured approach following the AHA algorithm. All information about the ACLS refresher course can be found at simulation.tirol/kurse/acls-refresher.